Peptides vs SARMs vs Prohormones: What Is the Difference?

Why This Confusion Exists

In online research-compound communities, "peptides," "SARMs," and "prohormones" are often discussed side-by-side, listed in the same vendor catalogs, and lumped together under the umbrella term "research chemicals." But chemically and mechanistically, the three are very different categories. Understanding the distinction matters because vendor selection, quality testing methods, and regulatory status differ significantly across the three.

This guide is a pure educational explainer. No recommendations, no compound names presented as suggestions — just the category map.

Peptides

What they are chemically

Peptides are short chains of amino acids — the same building blocks that make up proteins, just smaller. By convention, a peptide is usually defined as a chain of fewer than ~50 amino acids; anything longer is typically called a protein.

How they are made

Most research peptides are manufactured by **solid-phase peptide synthesis** (SPPS), an established chemistry technique that builds the chain one amino acid at a time on a solid resin support. After synthesis, the crude peptide is cleaved from the resin, purified (usually by HPLC), lyophilized, and packaged.

Mechanism class

Peptides typically act as **signaling molecules**. They bind to specific cell-surface receptors and trigger downstream cascades — the same way the body's own peptide hormones (insulin, glucagon, oxytocin) function. A peptide does not directly modify hormone levels by occupying steroid receptors.

Stability and handling

Peptides are generally fragile. They degrade with heat, light, pH extremes, and repeated freeze-thaw cycles. Most are shipped lyophilized (freeze-dried powder), reconstituted with [bacteriostatic water](/guides/what-is-bac-water/) before use, and stored cold.

Detection and testing

Peptide purity is measured by HPLC; identity is confirmed by mass spectrometry. The combination of the two — HPLC purity + mass-spec identity — is the standard COA package buyers should expect.

SARMs (Selective Androgen Receptor Modulators)

What they are chemically

SARMs are **small synthetic molecules** — not peptides, not steroids. They are typically non-steroidal compounds designed to interact with the androgen receptor in a tissue-selective way.

How they are made

Synthesized by standard organic-chemistry routes, often involving multi-step reactions specific to each compound's structure. They are not made by amino-acid chaining and have nothing structurally in common with peptides.

Mechanism class

SARMs act on the **androgen receptor** — the same receptor family that endogenous testosterone and synthetic anabolic steroids interact with. The "selective" in the name refers to the goal of differential activity across tissues (theoretically more anabolic effect on muscle and bone, less effect on prostate or hair follicles), although the degree of selectivity actually achieved varies by compound and is the subject of ongoing research.

Stability and handling

SARMs are typically more chemically stable than peptides. They tolerate room temperature in many forms, are usually shipped as solutions or capsules (not lyophilized powder), and have shelf lives measured in years rather than weeks.

Detection and testing

SARMs are tested differently than peptides. Identity is confirmed by NMR or GC/MS; purity is measured by HPLC against reference standards. Some vendors sell SARMs alongside peptides but they require fundamentally different quality-assurance workflows.

Regulatory status

In the US, SARMs are not approved for human use by the FDA and are scheduled by some sports-governance bodies as prohibited substances. They are widely sold "for research purposes only."

Prohormones

What they are chemically

Prohormones are **steroid precursors** — molecules structurally similar to endogenous steroid hormones that the body can convert into active hormones (or hormone analogues) through enzymatic pathways.

How they are made

Prohormones are synthesized by steroid-chemistry routes — the same general organic-chemistry tradition as anabolic steroids themselves. They share the four-ring steroid backbone characteristic of cholesterol-derived hormones.

Mechanism class

Prohormones act through the **same hormonal pathways as endogenous testosterone and its analogues**. Once converted in the body, they bind the androgen receptor (and sometimes other steroid receptors) in essentially the same way as a directly-administered anabolic steroid would.

Regulatory status

In the US, many prohormones were swept up by the Designer Anabolic Steroid Control Act of 2014 and are now classified as controlled substances. Others remain in a legal grey zone. Vendor catalogs in this category turn over frequently as compounds are scheduled.

The Categorical Map

To summarize the three categories side-by-side:

Why the Categories Should Not Be Mixed in Vendor Choice

A vendor that does peptides well does not necessarily do SARMs well, and vice versa. The quality-control infrastructure required is different: peptide vendors need HPLC + mass-spec for QC; SARMs vendors need different reference standards and analytical methods; prohormones require steroid-grade analytical chemistry plus a regulatory posture that handles controlled-substance scheduling.

Some vendors carry all three. Some carry only peptides. The [verified vendor directory](/vendors/) tracks peptide capability specifically — if a vendor also sells SARMs or prohormones, that's noted but it does not imply our verification covers those product lines.

Bottom Line

Peptides, SARMs, and prohormones are three distinct compound classes that happen to share a marketplace, not a chemistry. They have different mechanisms, different stability profiles, different testing requirements, and different regulatory positions. Treating them as interchangeable is a categorical error — both in research and in vendor selection.

For deeper coverage of how each category interacts with the others (and which combinations are commonly studied), the **Peptide Playbook** maps the broader research-compound ecosystem in detail.